Patients taking metformin, which is common in this population, should be aware that long-term use can reduce vitamin B12 levels, potentially contributing to neuropathy risk
Molecules, 19 (5), 6583-6596
d , HOP1 TPR1 reduces LET7 TPR and LET7 PPase interactions
The 12-week treatment window and 5 to 10% weight loss ceiling are insufficient for major transformations
Treatments like Wegovy and Zepbound (known as GLP-1 medications) are helping many people lose an average of 15% to 21% of their body weight, especially when combined with healthy eating, regular movement, and sustainable lifestyle changes
Pill (Rybelsus doses marketed for type 2 diabetes): tends to produce more modest weight loss in type 2 diabetes populations (for example, a realworld analysis reported ~ 3.70 kg at 26 weeks at the 14 mg dose) (Journal of Pharmacy Technology, 2024)